泽璟制药：11月14日召开董事会会议

Group 1 - The core point of the article is that Zejing Pharmaceutical (SH 688266) announced the convening of its third board meeting on November 14, 2025, to discuss the proposal for converting the company into an overseas fundraising joint-stock company [1] - For the year 2024, the revenue composition of Zejing Pharmaceutical is reported to be 99.73% from pharmaceutical manufacturing and 0.27% from other businesses [1] - As of the time of reporting, the market capitalization of Zejing Pharmaceutical is 28 billion yuan [1]